News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AFP Imaging Corporation (AFPC.OB) Co-Founder, Donald Rabinovitch, Retires


9/30/2009 6:56:06 AM

Bookmark and Share

ELMSFORD, N.Y.--(BUSINESS WIRE)--AFP Imaging Corporation announced that Donald Rabinovitch, co-founder and President of the company, has retired from AFP to pursue other opportunities. Mr. Rabinovitch has been with the company since its inception 30+ years ago. The company indicated that Mr. Rabinovitch’s duties and responsibilities will be transitioned to other members of the executive leadership team and that the role of President will not be filled at this time.

R. Scott Jones, AFP’s Chairman commented “We wish to thank Donald for his many years of dedication to the company. Over the years Donald has made many significant contributions to AFP including building AFP’s international business in over 100 global markets. We all wish him well in the future.”

AFP Imaging, a leading state of the art diagnostic imaging supplier with revenues of approximately $25 million, is a market leader with products for clinical applications in dental, medical and veterinary medicine under the brand names of AFP, DENT-X, EVA and NEWTOM. For over 30 years, the Company has developed and manufactured products that are installed in over 100,000 dental and medical facilities world-wide, including its latest digital imaging systems where it is a market leader in the Cone Beam 3-D x-ray imaging market. For additional corporate information please visit the company’s corporate web site at www.afpimaging.com.

The remarks contained in this press release and presented elsewhere by management from time to time contain forward-looking statements, which involve risks and uncertainties, including statements regarding the Company’s plans, objectives, expectations and intentions. The Company’s actual results may differ significantly from the results discussed in this press release or in other forward-looking statements presented by management. Among the factors that could cause actual results to differ materially include the failure of revenue on new products to develop as estimated, regulatory delays, loss of existing customers, the Company’s inability to meet increasing demand for its new products, general downward trends in the Company’s industry and other risks as described in the Company’s filings with the Securities and Exchange Commission. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company’s expectation or any change in events, conditions or circumstances on which such statement is based.

Contact:

AFP Imaging Corporation David Vozick, 914-592-6100


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES